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A Longer Polyalanine Expansion Mutation in the ARX Gene
Causes Early Infantile Epileptic Encephalopathy with Suppression-
Burst Pattern (Ohtahara Syndrome)
Mitsuhiro Kato, Shinji Saitoh, Atsushi Kamei, Hideaki Shiraishi, Yuki Ueda, Manami Akasaka,
Jun Tohyama, Noriyuki Akasaka, and Kiyoshi Hayasaka
Early infantile epileptic encephalopathy with suppression-burst pattern (EIEE) is one of the most severe and earliest forms
of epilepsy, often evolving into West syndrome; however, the pathogenesis of EIEE remains unclear. ARX is a crucial
gene for the development of interneurons in the fetal brain, and a polyalanine expansion mutation of ARX causes mental
retardation and seizures, including those of West syndrome, in males. We screened the ARX mutation and found a
hemizygous, de novo, 33-bp duplication in exon 2, 298_330dupGCGGCA(GCG)9, in two of three unrelatedmale patients
with EIEE. This mutation is thought to expand the original 16 alanine residues to 27 alanine residues
(A110_A111insAAAAAAAAAAA) in the ﬁrst polyalanine tract of the ARX protein. Although EIEE is mainly associated
with brain malformations, ARX is the ﬁrst gene found to be responsible for idiopathic EIEE. Our observation that EIEE
had a longer expansion of the polyalanine tract than is seen in West syndrome is consistent with the ﬁndings of earlier
onset and more-severe phenotypes in EIEE than in West syndrome.
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Early infantile epileptic encephalopathywith suppression-
burst pattern (EIEE) is one of the most severe and earliest
forms of epilepsy and has been known as “Ohtahara syn-
drome” since Ohtahara et al. ﬁrst reported it in 1976.1
Frequent tonic seizures or spasms start mainly in the neo-
natal period, with a speciﬁc ﬁnding of electroencephalog-
raphy (EEG)—namely, suppression-burst pattern charac-
terized by high-voltage bursts alternating with almost ﬂat
suppression phases at an approximately regular rate.2
Cerebral dysgenesis—including hemimegalencephaly, Ai-
cardi syndrome, and porencephaly—is often accompanied
by EIEE; however, the etiology is heterogeneous, and cryp-
togenic or idiopathic EIEE has been reported only in a
small number of patients. Familial occurrence of EIEE has
been reported only in a family with Leigh encephalopa-
thy.3 The transition from EIEE to West syndrome, which
is characterized by tonic spasms with clustering, arrest of
psychomotor development, and hypsarrhythmia on EEG,
occurs in 75% of patients with EIEE,4 and a common path-
ological mechanism between them has been suggested.
Recently, two novel genes, ARX and CDKL5, have been
found to be responsible for X-linked West syndrome or
infantile spasms (ISSX [MIM 308350]).5–8
ARX, the aristaless-related homeobox gene (GenBank
accession number NM_139058), is located in the human
chromosome Xp22 region and as a transcription factor is
essential for the development of cerebral interneurons.9
Mutation of ARX causes a wide variety of phenotypes,
from severe brain malformations like hydranencephaly or
lissencephaly lacking nonpyramidal or GABAergic inter-
neurons to nonsyndromic mental retardation, with a
strong correlation between genotype and phenotype.10,11
To identify the gene(s) underlying EIEE, we screened the
ARX mutation in three male patients with EIEE deﬁned
by brief tonic seizures and a suppression-burst pattern on
EEG with unknown etiology. Female patients were ex-
cluded, because even the null mutation of ARX causes less
severe phenotypes than West syndrome.10 All patients
showed a transition from EIEE to West syndrome and se-
vere developmental delay. Clinical information regarding
the patients in whom the ARX mutation was found was
as follows: patient 1 was the ﬁrst child of unrelatedhealthy
parents. He was born normally at term without asphyxia.
He suffered his ﬁrst seizure 40 min after birth. His eyes
deviated to the left with loss of consciousness, followed
by brief clonic movement, predominantly of the left leg
and arm. The seizure ceased after ∼1 min and recurred
four times. Physical examination demonstrated a micro-
penis (ﬁg. 1A). Findings from his blood and cerebrospinal
ﬂuid examinations were normal. A CT scan of his head
also showed normal results. EEG examination demon-
strated a suppression-burst pattern that was compatible
with EIEE (ﬁg. 1B). His seizure types shifted from (1) eye
deviation followed by brief clonic movement to (2) brief
tonic seizures and pedaling movements and then to (3)
brief tonic spasms in clusters. He tended to cry with an
opisthotonic posture. After 1 mo, EEG demonstrated a
transition to hypsarrhythmia, suggesting West syndrome,
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Figure 1. A, Photograph of patient 1’s external genitalia, showing a small penis with an apparently normal scrotum. B, Interictal
EEG of patient 1, showing an asynchronous pattern, with high-voltage slow wave bursts mixed with spikes and sharp waves, and a low-
voltage suppression background. C, Brain MRI of patient 1, demonstrating lateral ventricular dilatation with a frontal dominancy,
suggesting a small caudate nucleus, thin corpus callosum (not shown), and delayed myelination in the white matter.
but adrenocorticotropic hormone (ACTH) therapywasnot
effective. Combinations of multiple antiepileptic drugs,
such as phenobarbital (PB), carbamazepine (CBZ), cloba-
zam (CLB), valproic acid (VPA), vitamin B6, zonisamide
(ZNS), and potassium bromide, failed to stop his seizures,
and his development was profoundly delayed. He had not
acquired eye contact or head control by the age of 18 mo.
Consecutive brain magnetic resonance imaging (MRI) re-
vealed progressive brain atrophy (ﬁg. 1C). Patient 2 was
the second child of unrelated healthy parents, and his
elder sister was healthy. He was delivered spontaneously
at term, without asphyxia. After birth, he showed blinking
of the left eyelid and abrupt ﬂexion of the right arm and
left leg, suggesting seizures. At the age of 1 wk, he had
brief tonic seizures in clusters, with a suppression-burst
pattern on EEG (ﬁg. 2B). His physical ﬁndingswere normal
except for a small penis at the age of 1 mo. His routine
blood tests showed normal results except for a mild ele-
vation in liver transaminase (aspartate aminotransferase
[AST] 82 IU/liter, alanine aminotransferase [ALT] 34 IU/
liter). His brain MRI scan demonstrated a defect of the
cavum septi pellucidi and hypoplastic corpus callosum
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Figure 2. A, Brain MRI of patient 2 at the age of 8 WK shows dilatation of the anterior horns of the lateral ventricle and apparently
normal gyri. B, Interictal EEG of patient 2 shows a marked depression of background activity, intermixed with asymmetric paroxysmal
bursts.
(ﬁg. 2A). VPA, ZNS, PB, and clonazepam were given, but
his EEG at the age of 7 mo showed transformation to
hypsarrhythmia. With a diagnosis of West syndrome, he
received ACTH injections, with no effect. His develop-
ment was severely delayed.
Blood samples were collected from three patients with
sporadic EIEE and from their parents, after both informed
consent from the parents and approval from the Yamagata
University School of Medicine Institutional Review Board
were obtained. Genomic DNA was extracted according to
standard procedures and was ampliﬁed for all coding ex-
ons and ﬂanking introns of ARX. The primers and PCR
conditions have been described elsewhere.10 Direct se-
quence analysis of the PCR product of the ﬁrst half of
exon 2 was performed on an automated DNA sequencer
(ABI 310 [Applied Biosystems]). Other products were an-
alyzed by denaturing high-performance liquid chroma-
tography (DHPLC) performed using the Transgenomic
WAVE system (Transgenomic).
A hemizygous 33-bp duplication in exon 2,
298_330dupGCGGCA(GCG)9, which is thought to ex-
pand the original 16 alanine residues to 27 alanine resi-
dues (A110_A111insAAAAAAAAAAA) in the ﬁrst poly-
alanine tract of the ARX protein, was found in patient 1
(ﬁg. 3). Interestingly, the same mutation of the ARX gene
was also found in patient 2. No mutation was found in
their parents, suggesting that these mutations are in fact
de novo. The mothers, however, can still be gonadal mo-
saics, because gonadal or somatic mosaicism was docu-
mented for the ARX gene.12 Mutation screening of ARX
showed normal results in another patient.
ARX comprises ﬁve exons encoding a protein of 562 aa,
including a paired-class homeodomain and four repeats
of 7–16 alanine residues called “polyalanine tracts.”5,9 In
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Figure 3. The structure of exon 2 of the ARX gene and representative electropherograms in patient 1 and his parents. Both parents
have the wild-type sequence encoding 16 alanine residues, whereas the patient has a hemizygous mutant sequence with a duplication
of 33 bp, which encodes 11 alanine residues and results in an expanded repeat of 27 alanine residues. Polyalanine tract (A), nuclear
localization sequence (N), and homeobox (H) are illustrated in the structure of exon 2.9
nature, the maximum length of alanine repeats is 20.13
Mutation of the second polyalanine tract with eight ex-
panded alanine residues, which is the most common mu-
tation in ARX, results in nonsyndromic mental retarda-
tion; Partington syndrome (PRTS [MIM 309510]), which
is characterized by mental retardation and dystonicmove-
ments of the hands; and West syndrome or infantile
spasms in males.6,14 An expansion of 1–3 alanine residues
in the ﬁrst polyalanine tract containing the original 16
alanine residues has been reported in patients withmental
retardation, though the expansion of 1 alanine residuehas
been found in 1 of 188 control males.15,16 An expansion
of seven alanine residues in the ﬁrst polyalanine tract
causes West syndrome more severe than that caused by
the second polyalanine tract expansion mutation of the
ARX gene.14,17 So far, nine genes with expansion of the
polyalanine tract have been found to be responsible for
human diseases, and clinical observations demonstrate
a correlation between the length of the repeat and
the severity of the clinical phenotype and penetrance
in HOXD13 for synpolydactyly (SPD1 [MIM 186000]),18
PABPN1 for oculopharyngeal muscular dystrophy (OPMD
[MIM 164300]),19 and PHOX2B for congenital central hy-
poventilation syndrome (CCHS [MIM 209880]).20 Longer
expansion of the polyalanine tract causes a more severe
phenotype, as well as other diseases caused by triplet re-
peat expansion, such as fragile X syndrome (MIM 300624)
by FMR1 mutation, Huntington disease (HD [MIM
143100]) by IT15 mutation, and so on.21 As seen in both
of our patients, the onset of epileptic seizures in EIEE is
usually within the 1st mo after birth, which is distinctly
earlier than 3–9 mo of age as seen in West syndrome,
whereas the development outcome and life expectancy in
EIEE are worse than those in West syndrome.4 Our obser-
vation that EIEE had longer expansion of the polyalanine
tract than West syndrome may explain why EIEE starts
earlier and is more severe than West syndrome.
Although the function of polyalanine tracts remains un-
known, repeats of several alanine residues are frequent in
transcription factors and other proteins with nuclear lo-
calization.13 Extended alanine repeats of Hoxd13, Hoxa13,
Runx2, and Sox3 spontaneously form aggregates in the
cytoplasm.22 The smallest alanine-repeat expansion (7)
of Hoxd13 was predominantly located in the nucleus and
was well tolerated by the cells, whereas long expansions
(10 alanine residues) were cytotoxic and mainly lo-
cated in the cytoplasm.23 Therefore, the size of the alanine
expansions correlates with the severity of the cytoplasmic
aggregation. In vitro transfection experiments of the po-
lyalanine-expanded constructs of Arx cause nuclear ag-
gregation, ﬁlamentous nuclear inclusions, and an increase
in cell death, whereas cortical neurons transfected with
expanded polyalanine using whole-brain electroporation
form neuronal nuclear inclusions in vivo.24 Recently, the
human ARX protein was shown to be a potent transcrip-
tional repressor.25 Although the domain encompassing
polyalanine tracts 1 and 2 of ARX seems not to be sig-
niﬁcantly contributing to the repression activity, the ex-
pansions of either polyalanine tract 1 or 2 enhance tran-
scriptional repression activity in a manner dependent on
the length of the alanine expansion.25 These experimental
data suggest that the expansion of ARX polyalanine tracts
is harmful to neurons in a size-dependent manner.
Phenotypes caused by theARXmutation are largely clas-
siﬁed into two groups, a malformation group and a non-
malformation group.10 Premature termination mutations
and missense mutations within the homeobox of the ARX
gene mainly cause malformation of the brain and external
www.ajhg.org The American Journal of Human Genetics Volume 81 August 2007 365
genitalia, such as X-linked lissencephaly with abnormal
genitalia or hydranencephaly with abnormal genitalia
(XLAG [MIM 300215]) and Proud syndrome (MIM
300004), which consists of X-linked mental retardation,
agenesis of the corpus callosum, and abnormal genitalia.10
Missense mutations outside the homeobox and expan-
sions of polyalanine tracts lead to the nonmalformation
group, as mentioned above.5,15 No apparent brain or gen-
ital malformations have been reported in patients with
expansion of the polyalanine tracts, except for a boy show-
ing transsphenoidal encephalocele and agenesis of the
corpus callosum in a family affected with X-linkedmental
retardation26; however, both our patients with an expan-
sion of 11 alanine residues in the ﬁrst polyalanine tract
showedmicropenis. Among patients withXLAG,missense
mutations within the homeobox ofARX lead to less-severe
genital malformation than premature termination muta-
tions, which are thought to cause loss of function.10 An-
other patient without the ARX mutation in this report did
not have genital malformation. Similar genital ﬁndings
between a malformation group and EIEE caused by the
longest expansion of the polyalanine tract so far reported
in ARX bridges the gap between the malformation and
nonmalformation groups and suggests a common path-
ological mechanism between them.
Suppression-burst pattern has also been reported in a
patient with XLAG caused by a premature termination
mutation in ARX.27 The neuropathology of XLAG and
Arx-knockout mice indicates a defect in GABAergic inter-
neurons.9,11 Interestingly, an absence of GABA in the cer-
ebrospinal ﬂuid has been reported in a girl with EIEE and
migrational disorder.28 We hypothesize that an error of
GABAergic system is critical to the suppression-burst pat-
tern on EEG in patients with EIEE via dysfunction of in-
terneurons due to the ARX mutation. EIEE could be des-
ignated “interneuronopathy” as well as West syndrome.7
The sequence of polyalanine expansions we found is
an imperfect repeat of GCG including a triplet of GCA,
298_330dupGCGGCA(GCG)9. The ﬁrst 11 bp (GCGGCA-
GCGGC) recurrently appear just after the sequence of du-
plication from nucleotides 331 to 341. This suggests a pre-
disposition to recombination between the repeats and that
unequal crossing-over could be a mutational mechanism
of the expansion, as suggested for the second polyalanine
expansion of ARX and other polyalanine expansions.6,29
Knowledge of the genetic background of epilepsy is ex-
panding, and, to our knowledge, this is the ﬁrst report to
reveal the genetic cause of EIEE. Mutation screening of
ARX should be considered in patients with EIEE and in
other patients showing suppression burst on EEG or in-
fantile seizures with developmental delay.
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